Delusional Disorder

Delusional disorder is characterised by non-bizarre delusions persisting for ≥1 month without other prominent psychotic features. Functioning is relatively preserved.

Key Facts

Non-bizarre delusions (plausible real-life situations) persisting ≥1 month — key diagnostic feature Subtypes: Persecutory (most common ~50%), erotomanic, grandiose, jealous (Othello syndrome), somatic Prevalence ~0.02-0.03%; mean onset age 40-50 years; slight female predominance Functioning is relatively preserved — no prominent negative symptoms, thought disorder, or hallucinations First-line: Antipsychotic (risperidone 1-4mg, olanzapine 5-15mg) ± CBT — managed under NICE CG178 Jealous type carries significant risk of violence towards partner — urgent risk assessment required De Clérambault syndrome (erotomania): Delusion that a person of higher status is in love with the patient — risk of stalking Distinguished from schizophrenia by absence of bizarre delusions, prominent hallucinations, thought disorder, and negative symptoms

Overview

Key Facts

Delusional disorder involves fixed, systematised, non-bizarre delusions without the broader psychotic features of schizophrenia. Behaviour outside the delusional system is not markedly bizarre.

Epidemiology

Lifetime prevalence is approximately 0.02-0.03%. Mean onset is 40-50 years, later than schizophrenia. Persecutory subtype accounts for ~50% of cases. Slight female predominance.

Aetiology

  • Neurobiological: Dopaminergic dysfunction in limbic system, though less pronounced than schizophrenia
  • Psychological: Attribution biases, jumping-to-conclusions reasoning, social isolation, sensory impairment (hearing/vision loss in elderly)
  • Genetic: Some familial association with schizophrenia spectrum disorders
  • Social: Immigration, social adversity, loneliness

Pathophysiology

  • Abnormal salience attribution — brain assigns excessive significance to neutral stimuli
  • Jumping-to-conclusions bias — less evidence required before forming beliefs
  • Theory of mind deficits may promote paranoid ideation
  • Minimal structural brain changes compared to schizophrenia

Clinical Presentation

Subtypes

  • Persecutory: Being conspired against, followed, poisoned (most common)
  • Erotomanic: Another person (usually higher status) is in love with the patient
  • Grandiose: Exceptional talent, power, or special relationship
  • Jealous (Othello syndrome): Unfounded conviction of partner's infidelity
  • Somatic: Body function abnormality (emitting odour, parasites, deformity)

Key Clinical Features

  • Delusions are systematised and logically developed
  • Affect appropriate to delusional content
  • No prominent hallucinations, thought disorder, or negative symptoms
  • Relatively preserved functioning outside delusional system

Red Flags

  • Jealous type with aggression towards partner — significant violence risk
  • Persecutory delusions with retaliation plans — forensic risk
  • Erotomania with stalking behaviour — legal and safety implications
  • Somatic type with repeated inappropriate medical/surgical consultations

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
SchizophreniaBizarre delusions, hallucinations, thought disorder, negative symptomsMSE, longitudinal history
Bipolar maniaGrandiose delusions during mood episode, episodicMood history, collateral
Psychotic depressionMood-congruent delusions during severe depressionPHQ-9, MSE
OCDOvervalued ideas with insight, ego-dystonicY-BOCS
Body dysmorphic disorderPreoccupation with perceived physical defectClinical assessment
Organic psychosisMedical/neurological causeMRI, bloods, drug screen

Diagnosis / Investigation

Bedside

  • MSE: Delusional content, systematisation, insight assessment
  • Risk assessment: Particularly jealous and persecutory types
  • Collateral history: Patient may present convincing narrative

Bloods

  • TFTs, FBC, U&Es, LFTs, calcium, B12: Exclude organic causes
  • Urine drug screen: Exclude substance-induced psychosis

Special Tests

  • MRI brain: Consider in late-onset presentations
  • Audiometry/vision testing: Sensory impairment as contributing factor
  • Cognitive assessment: Exclude dementia in elderly

Management

Non-pharmacological

  • Build therapeutic alliance without colluding with or directly challenging delusion
  • CBT: Guided discovery to examine evidence for/against beliefs
  • Social interventions to address isolation

Pharmacological

  • Antipsychotics (often partially effective; patients frequently reluctant):
    • Risperidone 1-4mg OD or olanzapine 5-15mg OD
    • Lower doses than schizophrenia may suffice
    • Trial ≥6-8 weeks at adequate dose
  • SSRIs: If comorbid depression or somatic subtype
  • Managed under NICE CG178 (psychosis and schizophrenia)

Referral Criteria

  • All suspected cases — psychiatric assessment
  • Jealous type with partner at risk — urgent safeguarding
  • Stalking behaviour — forensic psychiatry
  • Failed outpatient treatment — inpatient assessment

Prognosis

  • Chronic course: ~50% persistent delusions; ~20% full remission; ~30% partial remission
  • Better prognosis: Female sex, acute onset, shorter duration, non-paranoid subtype
  • Jealous type: One of the most dangerous psychiatric presentations — significant partner violence risk
  • Functional outcome: Generally better than schizophrenia
  • Treatment engagement: Poor — many patients lack insight

Other Relevant Information

Delusional Disorder vs Schizophrenia

FeatureDelusional DisorderSchizophrenia
Delusion typeNon-bizarreOften bizarre
HallucinationsMinimal/absentProminent
Thought disorderAbsentCommon
Negative symptomsAbsentCommon
FunctioningRelatively preservedOften impaired
Age of onset40-50 years18-30 years
PrognosisBetterWorse